2021
DOI: 10.7150/thno.58755
|View full text |Cite
|
Sign up to set email alerts
|

Silicon nanowires decorated with platinum nanoparticles were applied for photothermal-enhanced sonodynamic therapy

Abstract: Sonodynamic therapy (SDT) triggered by ultrasound (US) can overcome pivotal limitations of photo-therapy owing to its high depth-penetration and low phototoxicity. However, there is still a need to develop more efficient sonosensitizes to enhance the therapy efficiency. Methods: In this study, Pt nanoparticles (Pt NPs) are reduced on silicon nanowires (SiNWs) by in situ reduction to prepare Si-Pt nanocomposites (Si-Pt NCs). Results: Si-Pt N… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
19
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 47 publications
(23 citation statements)
references
References 34 publications
0
19
0
Order By: Relevance
“…[ 15 ] Most currently available sonosensitizers are developed from conventional photosensitizers, including organic dyes (e.g., methylene blue, indocyanine green, acridine orange), [ 16–18 ] porphyrin‐derivatives (e.g., photofrin, hematoporphyrin, protoporphyrin IX, [ 19–21 ] and inorganic nanoparticles (e.g., silicon‐based nanoparticles, metal nanoparticles). [ 22–25 ] Yet, only limited SDT trials have entered the early preclinical phases owing to the inadequacies of the extant sonosensitizers in the ROS production, stability under sono‐irradiation, and biocompatibility, thus conferring modest therapeutic efficacy. Therefore, it is highly demanded to develop effective sonosensitizers with stable and sufficient ROS production for in vivo therapeutic applications.…”
Section: Introductionmentioning
confidence: 99%
“…[ 15 ] Most currently available sonosensitizers are developed from conventional photosensitizers, including organic dyes (e.g., methylene blue, indocyanine green, acridine orange), [ 16–18 ] porphyrin‐derivatives (e.g., photofrin, hematoporphyrin, protoporphyrin IX, [ 19–21 ] and inorganic nanoparticles (e.g., silicon‐based nanoparticles, metal nanoparticles). [ 22–25 ] Yet, only limited SDT trials have entered the early preclinical phases owing to the inadequacies of the extant sonosensitizers in the ROS production, stability under sono‐irradiation, and biocompatibility, thus conferring modest therapeutic efficacy. Therefore, it is highly demanded to develop effective sonosensitizers with stable and sufficient ROS production for in vivo therapeutic applications.…”
Section: Introductionmentioning
confidence: 99%
“…Integration of therapeutic modalities based on diverse mechanisms has provided opportunities for achieving enhanced anticancer treatment efficacy. [15][16][17] Benefiting from the broad absorption spectrum that could tail up to near-infrared (NIR) region, CDs were regarded as promising candidate for PTT, [18][19][20] which could convert the energy of external light into local heat and consequently leading to carcinoma cell damages. 10,21 PTT exhibited significant advantages in managing precise cancer treatment due to its intrinsic minimal invasiveness, spatiotemporal selectivity, and convenient operation.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, the combination of AuNPs and appropriate antibodies enhance Raman spectroscopy and detect the diseased tissue faster and more accurately [ 40 , 41 ]. AuNPs have been used in PTT that converts light energy into heat energy in the targeted area of skin and mucous membranes without damaging the surrounding healthy tissues, thereby destroying tumor cells [ [42] , [43] , [44] , [45] ]. AuNPs-based minimum invasive theranostics avoid the risk of surgical wound-related infection in the oral cavity.…”
Section: Introductionmentioning
confidence: 99%